KDR903 Kappa 900 DR
Implantable Pulse Generator (IPG)
KDR903 Kappa 900 DR
Information

Device Survival Probability

KD901_KD903_KD906_KDR901_KDR903_KDR906_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr at 123.0 mo                    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 99.9 99.9 99.9 99.9 99.9                    
% Including Normal Battery Depletion 99.6 99.5 99.2 98.7 97.7 95.5 87.2 63.7 33.5 11.0 3.3                    
#   117156 107784 98674 89941 81393 72830 61162 39043 14324 2099 328                    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

  • There are no advisories for this model.

Performance Notes For This Model

Information

Product Characteristics

Generator Type IPG
NBD Code DDDR
Max. Delivered Energy N/A
More
Connector Style 3.2mm Long Pin
Serial Number Prefix PKN
Mass 28.1 g
Volume 13.0 cc
Waveform N/A
X-Ray ID PKN
Hide this content
3.2mm Long Pin
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 7.7 8.6
Nominal 3.5 V (A, RV) 6.3 7.7
High 5.0 V (A, RV) 4.4 6.0
Footnote

Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; Atrial Fib Percent of Time 0 %Hide this content

Information

EOL Indication

From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Distribution Data

US Market Release2002-01-09
CE Approval Date2001-09-28
Registered USA Implants3168
Estimated Active USA Implants343
Normal Battery Depletions605
US Market Release2002-01-09
CE Approval Date2001-09-28
Estimated WW Distribution12703
Normal Battery Depletions691
Information

Malfunctions (USA)

Therapy Function Not Compromised 0
Therapy Function Compromised 3
Electrical Interconnect 3
Information

Malfunctions (WW)

Therapy Function Not Compromised 1
Electrical Interconnect 1
Therapy Function Compromised 6
Electrical Interconnect 5
Other 1
Information

Elective Replacement (ERI)

Telemetry indication. Rate and Mode change to 65 ppm and VVI (VOO/65 with magnet).

Data as of August 3, 2014

www.medtronic.com/productperformance 326050